Genetics of synucleins in neurodegenerative diseases
- PMID: 32740728
- DOI: 10.1007/s00401-020-02202-1
Genetics of synucleins in neurodegenerative diseases
Abstract
The SNCA locus currently has an indisputable role in Parkinson's disease and other synucleinopathies. The role of genetic variability in the other members of the synuclein family (SNCB and SNCG) in disease is far less clear. In this review, we critically assess the pathogenicity, main characteristics, and roles of genetic variants in these genes reported to be causative of synucleinopathies. We also summarize the different association signals identified in the SNCA locus that have been associated with risk for disease. We take a bird's eye view of the variability currently reported in the general population for the three genes and use these data to infer on the potential relationship between each of the genes and human disease.
Keywords: Genetics; SNCA; SNCB; SNCG; Synuclein; Synucleinopathies.
References
-
- Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OMA (2007) Gamma-synuclein and the progression of cancer. FASEB J 21:3419–3430 - PubMed
-
- Alexander DM, Williams LM, Gatt JM, Dobson-Stone C, Kuan SA, Todd EG et al (2007) The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol Psychol 75:229–238 - PubMed
-
- Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B et al (2013) Alpha-synuclein p. H50Q, a novel pathogenic mutation for Parkinson’s disease. Mov Disord 28:811–813 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
